The top 3 holdings of LABU are Alnylam Pharmaceuticals (ALNY) (1.95%), EXACT Sciences (EXAS) (1.842%) and Blueprint Medicines (BPMC) (1.826%).

FUND	HOLDING	% OF FUND	VALUE ($)
LABU	Alnylam Pharmaceuticals (ALNY)	1.95%	$11.9M
LABU	EXACT Sciences (EXAS)	1.842%	$11.2M
LABU	Blueprint Medicines (BPMC)	1.826%	$11.1M
LABU	Neurocrine Biosciences (NBIX)	1.784%	$10.9M
LABU	Natera (NTRA)	1.726%	$10.5M
LABU	United Therapeutics (UTHR)	1.643%	$10M
LABU	Incyte (INCY)	1.543%	$9.4M
LABU	Insmed (INSM)	1.537%	$9.3M
LABU	Gilead Sciences (GILD)	1.493%	$9.1M
LABU	Biogen (BIIB)	1.464%	$8.9M
LABU	Amgen (AMGN)	1.443%	$8.8M
LABU	Exelixis (EXEL)	1.415%	$8.6M
LABU	Vertex Pharmaceuticals (VRTX)	1.403%	$8.5M
LABU	AbbVie (ABBV)	1.375%	$8.4M
LABU	Moderna (MRNA)	1.237%	$7.5M
LABU	Madrigal Pharmaceuticals (MDGL)	1.226%	$7.5M
LABU	Regeneron Pharmaceuticals (REGN)	1.101%	$6.7M
LABU	BridgeBio Pharma (BBIO)	1.092%	$6.6M
LABU	Biomarin Pharmaceutical (BMRN)	1.071%	$6.5M
LABU	Revolution Medicines (RVMD)	0.955%	$5.8M
LABU	TG Therapeutics (TGTX)	0.954%	$5.8M
LABU	Ionis Pharmaceuticals (IONS)	0.882%	$5.4M
LABU	Halozyme Therapeutics (HALO)	0.853%	$5.2M
LABU	Roivant Sciences (ROIV)	0.803%	$4.9M
LABU	Crispr Therapeutics (CRSP)	0.8%	$4.9M

Holdings are tracked for approximately 2000 ETFs.